Keywords: teva, copaxone, trials, news, presented, data, extension

Teva: Copaxone trials news

Article | 13 November 1995

Print This

- Teva has presented data from an extension period of its Phase III trials of its multiple sclerosis drug Copaxone (copolymer-1), ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in